Adare, Teva Say Apotex Infringed Patent With Amrix Generic

Law360, New York (September 30, 2016, 3:48 PM EDT) -- Apotex Inc.’s application to sell a generic version of the muscle relaxant Amrix infringes Adare Pharmaceuticals Inc. and a Teva Pharmaceutical Industries Ltd. unit’s patent for the branded drug, the companies told a Delaware federal court Thursday.

New Jersey-based Adare and Ivax International GmbH, a Swiss arm of Teva, said Apotex infringed U.S. Patent Number 9,399,025 when submitting an abbreviated new drug application to the U.S. Food and Drug Administration and asked the court to block the company from making, marketing or selling the generic until...
To view the full article, register now.